•
Dec 31, 2020

AptarGroup Q4 2020 Earnings Report

AptarGroup showcased resilient business with strong second half results and record annual free cash flow.

Key Takeaways

AptarGroup reported strong fourth quarter performance with reported sales growth of 12% and core sales growth of 5%. The Pharma and Food + Beverage segments achieved double-digit sales growth, while the Beauty + Home segment saw modest core sales decline. The company achieved increased earnings per share and strong cash flow from operations and free cash flow.

Reported sales grew 12%; core sales grew 5%.

Pharma and Food + Beverage segments achieved double-digit sales growth.

Reported earnings per share totaled $0.79.

Adjusted earnings per share totaled $0.92.

Total Revenue
$749M
Previous year: $671M
+11.6%
EPS
$0.92
Previous year: $0.8
+15.0%
Total Core Sales Growth
5%
Previous year: -1%
-600.0%
Beauty + Home Core Sales Growth
-2%
Previous year: -5%
-60.0%
Pharma Core Sales Growth
10%
Previous year: 4%
+150.0%
Gross Profit
$279M
Previous year: $236M
+18.4%
Cash and Equivalents
$300M
Previous year: $242M
+24.0%
Free Cash Flow
$116M
Previous year: $78.6M
+47.7%
Total Assets
$3.99B
Previous year: $3.56B
+12.0%

AptarGroup

AptarGroup

AptarGroup Revenue by Segment

Forward Guidance

Aptar expects earnings per share for the first quarter of 2021 to be in the range of $0.86 to $0.94, based on an effective tax rate range of 28% to 30%. The company anticipates continued solid growth in injectables components, active material solutions, and dispensing systems for sanitizers, cleaners, and food products.

Positive Outlook

  • Continued solid growth in injectables components.
  • Continued solid growth in active material solutions.
  • Continued solid growth in dispensing systems for sanitizers.
  • Continued solid growth in dispensing systems for cleaners.
  • Continued solid growth in dispensing systems for food products.

Challenges Ahead

  • Demand in the beauty fragrance market is expected to remain under pressure.
  • Demand in the on-the-go beverage markets is expected to remain under pressure.
  • Experiencing a drawdown of inventories by certain prescription drug customers.
  • Experiencing a drawdown of inventories by certain consumer health care customers.
  • Fewer non-critical doctor visits.

Revenue & Expenses

Visualization of income flow from segment revenue to net income